BIOCANCELL THERAPEUTICS INC.: key financial figures for fiscal year 2011 (in USD), standardized from XBRL/iXBRL filings by Hub-Equity:
- Net Income/Loss (FY2011)
- -$6.0M
- Total Assets (FY2011)
- $1.4M
- Total Equity (FY2011)
- -$3.5M
- Cash Flows from Operating Activities (FY2011)
- -$5.1M
Source: BIOCANCELL THERAPEUTICS INC. 10-K filing (FY2011). Full income statement, balance sheet and cash flow, restatement-aware and traceable to the source filing, at Hub-Equity.
